Biomarkers for a successful pregnancy

Euroscicon, Cineworld: The O2, Peninsula Square, London, UK
Thursday, 17 October 2013

Successful biomarker profiling in pregnant or prenatal women could not only help predict the pregnancy risk to mothers, but also survival rate of the unborn child and any possible future complications. There is a wide range of possibility for using biomarkers in pregnancy and prenatal testing.  For example,  research is currently being undertaken to identify biomarkers for

Identifying 

·         ectopic pregnancy.

·         potential rejection of pregnancy by the mother

·         possible cardiovascular issues

·         maternal autoimmune development

·         hypertensive disorders

Assessing 

·         pregnancy outcome

Revealing 

·         Maternal Alcohol Consumption

·         Maternal tobacco use

Avoiding 

·         reducing multiple pregnancy

to highlight just a few. This event aims to focus on the current research in this area and discuss the way forward in using biomarkers as a predictive and diagnostic tool to improve pregnancy outcome internationally

Dr Andrew Horne, The Queen’s Medical Research Institute, University of Edinburgh

Professor Gordon C S Smith, Professor & Head of Department,Obstetrics and Gynaecology,Cambridge University

Dr KM Gillespie, Diabetes and Metabolism Unit,  University of Bristol

Dr Alexander Heazell, Manchester University, UK